Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

We are delighted to present the latest edition of touchREVIEWS in Oncology & Haematology. This issue underscores the evolving landscape of cancer therapeutics, showcasing advances across a wide range of malignancies, from haematologic diseases to solid tumours, through novel mechanisms, emerging biomarkers and personalized treatment strategies. We begin with an editorial by Isabela Wen-Chi Chang […]

Benjamin A Weinberg, ASCO GI22: Pivotal Studies in Colorectal Cancer

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 18th 2022

Professor Benjamin A Weinberg (Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA) summarises key data from pivotal studies in colorectal cancer that were presented at the ASCO Gastrointestinal Cancers Symposium 2022.

Clinical trial information: jRCT1031200006

Clinical Trial Registration Number: UMIN000008866

Clinical trial information: NCT033501260.

Questions

  1.          What has the GALAXY study taught us about ctDNA dynamics and clinical outcomes in the management of patients with resectable colorectal cancer (CRC)? (00:15-01:45)
  2.           Following the RESPECT study, what should be the preferred first-line treatment for patients with metastatic (m)CRC aged 75+? (01:45-03:30)
  3.           According to the latest GERCOR NIPICOL data, when is the best time to stop immunotherapy in patients with microsatellite instability-high/mismatch repair deficient mCRC? (03:30-05:01)
  4.           What have we learned about the use of neoadjuvant dostarlimab for MSI-H locally advanced CRC? (05:01-06:10)
  5.           What is the potential of BEACON plus nivolumab for BRAF V600E mutated mCRC? (06:10-07:52)

Speaker Disclosure: Benjamin A Weinberg has no conflicts of interest to declare in relation to this video.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.

Filmed in coverage of the ASCO Gastrointestinal Cancers Symposium 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup